is mounjaro a semaglutide compound Concerns Surrounding Compounded GLP-1s Mount As Shortages of Tirzepatide, End New Weight Management Program Q&A
Description
Always use the smallest barrel that fits your dose
CrossRef Zhang L, Chen X, Xu Y, et al
Clinical trial meta-analyses show a statistically significant association between semaglutide (and GLP-1 agonists broadly) and increased DVT risk
This cardiovascular protective effect is something other GLP-1 medications have not yet demonstrated at the same level, making Wegovy widely regarded by clinicians as the current gold-standard option specifically for obesity with cardiovascular risk
Patients with type 2 diabetes show 46.5% discontinuation rates within the first year, compared to 64.8% among patients without diabetes
